Prognostic value of glycaemic variability for mortality in cardiogenic shock patients: a retrospective cohort study.

ABSTRACT:

Background

Cardiogenic shock (CS) represents a life-threatening cardiovascular condition with high mortality rates. Effective glycaemic management plays a critical role in treating CS patients. Glycaemic variability (GV), an increasingly recognized indicator of glycaemic control, has demonstrated significant associations with adverse outcomes across various disease. The prognostic implications of GV specifically in CS remain unclear. We investigated whether GV independently predicts all-cause mortality following ICU admission in this patient population.

Methods

This retrospective cohort study analyzed data from the Medical Information Mart for Intensive Care IV 3.0 (MIMIC-IV 3.0) database, focusing on patients with CS. The study endpoints were 30-day, 90-day, and 360-day all

SUBMITTER: Xie L 

PROVIDER: S-EPMC12512319 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature